Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FDJK0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,721
Award facts
- Contract value 100% obligated
- $12,720.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12.72K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of JAKAFI 5 mg. This firm fixed-price delivery order, awarded on January 5, 2026, represents a component purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. The contract was issued without set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group has been registered in the System for Award Management since 2001 and maintains SAM registration as a woman-owned small business entity.
This delivery order falls under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for pharmaceutical products supporting Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award IDC under this program (contract SPE2DR) valued at $499.9M with an ultimate completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. The vendor's comprehensive product portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it as a critical supplier within the federal pharmaceutical supply chain for DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FDJK0?
SPE2DR26FDJK0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FDJK0 worth?
The government has obligated $12,721 on SPE2DR26FDJK0.
Is contract SPE2DR26FDJK0 an order under another contract?
Yes. SPE2DR26FDJK0 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJK0 competed?
The extent of competition for SPE2DR26FDJK0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award